logo
#

Latest news with #KeinHingInternationalBerhad

Kein Hing International Berhad Full Year 2025 Earnings: EPS: RM0.11 (vs RM0.14 in FY 2024)
Kein Hing International Berhad Full Year 2025 Earnings: EPS: RM0.11 (vs RM0.14 in FY 2024)

Yahoo

time27-06-2025

  • Business
  • Yahoo

Kein Hing International Berhad Full Year 2025 Earnings: EPS: RM0.11 (vs RM0.14 in FY 2024)

Revenue: RM327.9m (up 9.8% from FY 2024). Net income: RM12.1m (down 20% from FY 2024). Profit margin: 3.7% (down from 5.0% in FY 2024). The decrease in margin was driven by higher expenses. EPS: RM0.11 (down from RM0.14 in FY 2024). AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. All figures shown in the chart above are for the trailing 12 month (TTM) period The primary driver behind last 12 months revenue was the Manufacturing segment contributing a total revenue of RM348.2m (106% of total revenue). Notably, cost of sales worth RM305.6m amounted to 93% of total revenue thereby underscoring the impact on earnings. The most substantial expense, totaling RM10.2m were related to Non-Operating costs. This indicates that a significant portion of the company's costs is related to non-core activities. Explore how KEINHIN's revenue and expenses shape its earnings. Kein Hing International Berhad shares are down 5.5% from a week ago. Before you take the next step you should know about the 2 warning signs for Kein Hing International Berhad that we have uncovered. — Investing narratives with Fair Values A case for TSXV:USA to reach USD $5.00 - $9.00 (CAD $7.30–$12.29) by 2029. By Agricola – Community Contributor Fair Value Estimated: CA$12.29 · 0.9% Overvalued DLocal's Future Growth Fueled by 35% Revenue and Profit Margin Boosts By WynnLevi – Community Contributor Fair Value Estimated: $195.39 · 0.9% Overvalued Historically Cheap, but the Margin of Safety Is Still Thin By Mandelman – Community Contributor Fair Value Estimated: SEK232.58 · 0.1% Overvalued View more featured narratives — Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Kein Hing International Berhad Third Quarter 2025 Earnings: EPS: RM0.028 (vs RM0.017 in 3Q 2024)
Kein Hing International Berhad Third Quarter 2025 Earnings: EPS: RM0.028 (vs RM0.017 in 3Q 2024)

Yahoo

time27-03-2025

  • Business
  • Yahoo

Kein Hing International Berhad Third Quarter 2025 Earnings: EPS: RM0.028 (vs RM0.017 in 3Q 2024)

Revenue: RM74.8m (flat on 3Q 2024). Net income: RM3.00m (up 66% from 3Q 2024). Profit margin: 4.0% (up from 2.4% in 3Q 2024). EPS: RM0.028 (up from RM0.017 in 3Q 2024). AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. All figures shown in the chart above are for the trailing 12 month (TTM) period Kein Hing International Berhad shares are down 1.4% from a week ago. We should say that we've discovered 1 warning sign for Kein Hing International Berhad that you should be aware of before investing here. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store